<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02800512</url>
  </required_header>
  <id_info>
    <org_study_id>5160158</org_study_id>
    <nct_id>NCT02800512</nct_id>
  </id_info>
  <brief_title>SCP vs HUSLS for Pelvic Organ Prolapse Repair</brief_title>
  <official_title>Robotic Sacrocolpopexy Versus High Uterosacral Ligament Suspension: A Randomized Trial</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Loma Linda University</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Loma Linda University</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The purpose of this study is to compare the effectiveness of R-SCP versus HUSLS for treatment&#xD;
      of pelvic organ prolapse.&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      To compare the effectiveness of Robotic Sacrocolpopexy versus vaginal High Uterosacral&#xD;
      Ligament Suspension for treatment of pelvic organ prolapse. Both surgeries are standard of&#xD;
      care and are equally and widely used throughout the country with well known safety and&#xD;
      efficacy.&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">December 2016</start_date>
  <completion_date type="Anticipated">August 2022</completion_date>
  <primary_completion_date type="Anticipated">August 2022</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Basic Science</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Pelvic Organ Prolapse Quantification (pop-q) to asses change post operatively</measure>
    <time_frame>3 month post operative</time_frame>
    <description>Pelvic organ prolapses are graded with the Pelvic Organ Prolapse Quantification (POP-Q) System.</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Pelvic Organ Prolapse Quantification (pop-q) to asses change post operatively</measure>
    <time_frame>6 month post operative</time_frame>
    <description>Pelvic organ prolapses are graded with the Pelvic Organ Prolapse Quantification (POP-Q) System.</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Pelvic Organ Prolapse Quantification (pop-q) to asses change post operatively</measure>
    <time_frame>12 month post operative</time_frame>
    <description>Pelvic organ prolapses are graded with the Pelvic Organ Prolapse Quantification (POP-Q) System.</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>questionnaires PFDI-7</measure>
    <time_frame>6 month post operative</time_frame>
    <description>Subject will fill out the PFDI-7 questionnaire</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>questionnaires PFDI-7</measure>
    <time_frame>12 month post operative</time_frame>
    <description>Subject will fill out the PFDI-7 questionnaire</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>questionnaires PFIQ-20</measure>
    <time_frame>6 month post operative</time_frame>
    <description>Subject will fill out the PFIQ-20 questionnaire</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>questionnaires PFIQ-20</measure>
    <time_frame>12 month post operative</time_frame>
    <description>Subject will fill out the PFIQ-20 questionnaire</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>questionnaires PISQ-12</measure>
    <time_frame>6 month post operative</time_frame>
    <description>Subject will fill out the PISQ-12 questionnaire</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>questionnaires PISQ-12</measure>
    <time_frame>12 month post operative</time_frame>
    <description>Subject will fill out the PISQ-12 questionnaire</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>questionnaires PGI-I</measure>
    <time_frame>6 month post operative</time_frame>
    <description>Subject will fill out the PGI-I</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>questionnaires PGI-I</measure>
    <time_frame>12 month post operative</time_frame>
    <description>Subject will fill out the PGI-I</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">112</enrollment>
  <condition>Pelvic Organ Prolapse</condition>
  <condition>Cystocele</condition>
  <condition>Rectocele</condition>
  <condition>Enterocele</condition>
  <arm_group>
    <arm_group_label>Sacrocolpopexy</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Robotic sacrocolpopexy</description>
  </arm_group>
  <arm_group>
    <arm_group_label>HUSLS</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Vaginal high uterosacral ligament suspension</description>
  </arm_group>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>Robotic sacrocolpopexy</intervention_name>
    <description>Sacrocolpopexy is a procedure to surgically correct vaginal vault prolapse where mesh is used to hold the vagina in the correct anatomical position. Robotic assistance is a minimally invasive method to perform this abdominal procedure.</description>
    <arm_group_label>Sacrocolpopexy</arm_group_label>
    <other_name>R-SCP</other_name>
  </intervention>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>high uterosacral ligament suspension</intervention_name>
    <description>Utilizing uterosacral ligaments to support the vaginal cuff can be performed vaginally-by passing sutures bilaterally through the uterosacral ligaments. near the level of the ischial spine. HUSLS is a vaginal minimally invasive procedure for POP.</description>
    <arm_group_label>HUSLS</arm_group_label>
    <other_name>HUSLS</other_name>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  18 Years of age or older&#xD;
&#xD;
          -  Signed Informed Consent&#xD;
&#xD;
          -  Symptomatic pelvic organ prolapse,&#xD;
&#xD;
          -  Willing and able to complete all study visit&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  Non-High Uterosacral Ligament Suspension (unable to do HUSLS at time of surgery),&#xD;
&#xD;
          -  Dementia or considered unable to complete questionnaires&#xD;
&#xD;
               1. Hx of Alzheimer Disease&#xD;
&#xD;
               2. Hx multiple strokes or other neurologic condition&#xD;
&#xD;
               3. Caregiver states the subject is unable to complete&#xD;
&#xD;
               4. MDs opinion&#xD;
&#xD;
          -  Inability to complete follow up visits due to transportation issues&#xD;
&#xD;
               1. No access to transportation (ie. does not have vehicle)&#xD;
&#xD;
               2. Live &gt; 2 hours from LLUH&#xD;
&#xD;
               3. Does not have financial means&#xD;
&#xD;
          -  Congenital anomalies&#xD;
&#xD;
               1. Bladder Exstrophy&#xD;
&#xD;
               2. Connective tissue disease&#xD;
&#xD;
               3. Neovaginal prolapse&#xD;
&#xD;
               4. Prolapse of sex change vagina&#xD;
&#xD;
          -  Chronic pelvic pain&#xD;
&#xD;
               1. &gt; 6 months of pelvic pain of undetermined origin&#xD;
&#xD;
               2. not cyclic pain (eg. period pain or dysmenorrhea)&#xD;
&#xD;
               3. Patient has comorbidities of CPP&#xD;
&#xD;
               4. Fibromyalgia&#xD;
&#xD;
               5. Interstitial cystitis&#xD;
&#xD;
               6. Vulvodynia&#xD;
&#xD;
          -  Contraindications to Mesh,&#xD;
&#xD;
               1. Opposition to the use mesh (ie. due to religious beliefs)&#xD;
&#xD;
               2. History of mesh complications in past&#xD;
&#xD;
          -  Pregnant or planning to become pregnant during the study period.&#xD;
      </textblock>
    </criteria>
    <gender>Female</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>100 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Sam Siddighi</last_name>
    <role>Principal Investigator</role>
    <affiliation>Loma Linda University Health Care</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Sam Siddighi, MD</last_name>
    <phone>9095582782</phone>
    <email>ssiddighi@llu.edu</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Christine Cota</last_name>
    <phone>9095582595</phone>
    <email>ccota@llu.edu</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>Loma Linda University URO/GYN</name>
      <address>
        <city>Loma Linda</city>
        <state>California</state>
        <zip>92354</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Sam Siddighi</last_name>
      <phone>909-558-2782</phone>
      <email>ssiddighi@llu.edu</email>
    </contact>
    <contact_backup>
      <last_name>Christine Cota</last_name>
      <phone>9095582595</phone>
      <email>ccota@llu.edu</email>
    </contact_backup>
    <investigator>
      <last_name>Sam Siddighi</last_name>
      <role>Principal Investigator</role>
    </investigator>
    <investigator>
      <last_name>Jeffery Hardesty</last_name>
      <role>Sub-Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <reference>
    <citation>Elliott DS, Krambeck AE, Chow GK. Long-term results of robotic assisted laparoscopic sacrocolpopexy for the treatment of high grade vaginal vault prolapse. J Urol. 2006 Aug;176(2):655-9.</citation>
    <PMID>16813916</PMID>
  </reference>
  <reference>
    <citation>Margulies RU, Rogers MA, Morgan DM. Outcomes of transvaginal uterosacral ligament suspension: systematic review and metaanalysis. Am J Obstet Gynecol. 2010 Feb;202(2):124-34. doi: 10.1016/j.ajog.2009.07.052. Review.</citation>
    <PMID>20113690</PMID>
  </reference>
  <verification_date>September 2021</verification_date>
  <study_first_submitted>April 26, 2016</study_first_submitted>
  <study_first_submitted_qc>June 14, 2016</study_first_submitted_qc>
  <study_first_posted type="Estimate">June 15, 2016</study_first_posted>
  <last_update_submitted>September 16, 2021</last_update_submitted>
  <last_update_submitted_qc>September 16, 2021</last_update_submitted_qc>
  <last_update_posted type="Actual">September 20, 2021</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>pelvic organ prolapse</keyword>
  <keyword>cystocele</keyword>
  <keyword>rectocele</keyword>
  <keyword>enterocele</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Rectocele</mesh_term>
    <mesh_term>Cystocele</mesh_term>
    <mesh_term>Prolapse</mesh_term>
    <mesh_term>Pelvic Organ Prolapse</mesh_term>
    <mesh_term>Hernia</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

